The Centers for Medicare and Medicaid Services (CMS) published an Advance Notice of Proposed Rulemaking with Comment (ANPRM) on October 30, 2018. The ANPRM provides for 60 days of comment before an actual proposed rule is released. The actual proposed rule when issued should provide for at least another 60 days of comment. The ANPRM solicits public comments on potential options to test the use of an International Pricing Index (IPI) Model for separately payable Part B drugs and biologics. CMS is considering issuing a proposed rule in the spring of 2019 on the IPI Model. The potential IPI Model would start in the spring of 2020 and operate for five years, until the spring of 2025.

Comments are due by 5 p.m. EST on December 31, 2018. The link to comment is on page four of this document and enter this file code for the rule: CMS-5528-ANPRN.

Deadline 12/31/18 – Opportunity to Comment on CMS Proposed Part B Drug Plan